The Climate Crisis is Global, but These 6 Places Face the Most Severe Consequences
Climate change is expected to affect every country in the world, but its impact will not be felt equally across all regions and some will be worse hit than others because of a range of different threats. Developing countries, places with widespread poverty, and countries with ineffective governments sometimes face the gravest risks from the changing climate, and are usually poorly equipped to find ways to prepare for and prevent environmental threats. Measuring the future impact of climate change is very challenging, because scientists’ climate change projections cannot be completely exact and because there are many different factors that come into play such as the risk of extreme weather events and rising temperatures. There are other non-climatic factors that also determine how severely a city or country will be impacted by climate change. Niall Smith, who analyzes regions’ climate change vulnerability for the global risk consulting firm Maplecroft, tells TIME that it’s also necessary to weigh in what’s happening politically and socially in a region to figure out if the country can prepare. “The places with the least level of economic development are certainly in line to feel the impacts with the greatest degree, partially just due to their geographic fate — or their location — but more so based on the socio-economic and governance factors,” says Smith. Many developing countries are also uniquely vulnerable, says Kelly Levin ...
CONCLUSIONS: At present, lacking an effective vaccine, the prevention and implementation of standard precautions such as chemoprophylaxis, represent the safest strategy to put into practice to eradicate the disease especially for the groups at greater risk as visiting friends and relatives. PMID: 32242538 [PubMed - in process]
Authors: Godman B, McCabe H, D Leong T, Mueller D, Martin AP, Hoxha I, Mwita JC, Rwegerera GM, Massele A, Costa JO, do Nascimento RCRM, Lemos LLP, Tachkov K, Milushewa P, Patrick O, Niba LL, Laius O, Sefah I, Abdulsalim S, Soleymani F, Guantai AN, Achieng L, Oluka M, Jakupi A, Logviss K, Hassali MA, Kibuule D, Kalemeera F, Mubita M, Fadare J, Ogunleye OO, Saleem Z, Hussain S, Bochenek T, Mardare I, Alrasheedy AA, Furst J, Tomek D, Markovic-Pekovic V, Rampamba EM, Alfadl A, Amu AA, Matsebula Z, Phuong TNT, Thanh BN, Chichonyi Kalungia A, Zaranyika T, Masuka N, Olaru ID, Wale J, Hill R, Kurdi A, Timoney A, Campbell S, Meyer ...
PARIS (Reuters)—Sanofi SA will be able to provide millions of doses of hydroxychloroquine (HCQ) for patients with the illness caused by the novel coronavirus if the old malaria drug proves successful in clinical trials, its chief executive tells Reuters on Thursday. Paul Hudson, who became CEO of the French drugmaker in September, said in an... [Read More]
Treating patients with "moderate" COVID-19 is a way to stop the disease from progressing to a severe stage that would require mechanical ventilation.
[MSF] After more than a decade of armed conflict, outbreaks of severe malnutrition, malaria, measles and cholera, approximately 1.5 million internally displaced people (IDPs) in Borno state now face the spectre of COVID-19. Many live in vastly overcrowded camps with poor water and sanitation facilities, limited supplies of hygiene essentials such as soap and water, and often no individual space at all. Functioning health infrastructure in Borno is scarce, and the capacity to refer patients is extremely limited.
French virologist Didier Raoult was one of the first to administer the malaria drug to Covid-19 patients
Sanofi SA will be able to provide millions of doses of hydroxychloroquine for patients with the illness caused by the novel coronavirus if the old malaria drug proves successful in clinical trials, its chief executive told Reuters on Thursday.
Limited supplies of the anti-malarials chloroquine and hydroxychloroquine could hinder plans to use them to treat COVID-19, experts warned Thursday, adding that the use poses a danger for patients already on the drugs.
Authors: Schlipköter U, Flahault A Abstract The past two centuries have seen enormous achievements in control of infectious diseases, previously the leading cause of death, in large measure due to sanitation and food safety, vaccines, antibiotics and improved nutrition. This has led people to put their faith in the notion that medical science would succeed in overcoming the remaining obstacles. Vaccination has eradicated smallpox, nearly eradicated poliomyelitis and greatly reduced many other highly dangerous infections such as diphtheria, tetanus and measles. New diseases such as HIV and new forms of influenz...
AbstractMalaria, an important parasitic disease worldwide, still has diagnostic challenges in the laboratory. Many studies have been conducted on the detection ability of haematology analysers for malaria. We evaluated the Sysmex XN-series analyser as a tool for detection of malaria by analysing the leukocyte cell population data (LCPD), scattergrams and associated Flow Cytometry Standard (FCS) data from both the WNR (white cell nucleated) and WDF (white cell differential) channels. 1281 clinically suspected cases of malaria were screened for malaria by peripheral blood smear examination and were run in the Sysmex XN-1000 ...
More News: Budgets | Child Development | Children | Economy | Environmental Health | Fiji Health | Fish | Girls | Government | Guinea Health | Haiti Health | Kiribati Health | Malaria | Middle East Health | Nigeria Health | Philippines Health | Politics | Rural Health | Science | Smokers | Sodium Chloride | Study | UAE Health | United Nations | Yemen Health